Immune‑related gene expression in skin, inflamed and keloid tissue from patients with keloids

Shan,Mengjie; Liu,Hao; Song,Kexin; Liu,Shu; Hao,Yan; Wang,Youbin

doi:10.3892/ol.2022.13192

Immune‑related gene expression in skin, inflamed and keloid tissue from patients with keloids

Authors:
- Mengjie Shan
- Hao Liu
- Kexin Song
- Shu Liu
- Yan Hao
- Youbin Wang
View Affiliations

Affiliations: Department of Plastic Surgery, Peking Union Medical College Hospital, Beijing 100730, P.R. China, Department of General Surgery, Civil Aviation General Hospital, Beijing 100123, P.R. China
Published online on: January 5, 2022 https://doi.org/10.3892/ol.2022.13192
Article Number: 72
Copyright: © Shan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Keloids are a tumor‑like fibroproliferative skin disease that could cause disfigurement and disability. The pathological mechanisms underlying this condition remain unclear, particularly the progression from normal healthy skin to inflammatory skin tissue, then keloid. In the present study, three immune‑related gene expression profiling datasets, were obtained from normal skin tissue (N group), inflamed tissue (I group) and keloid tissue samples from patients with keloids (K group). This sample grouping represents the primary steps of keloid formation, from normal to inflammatory, and finally to keloid tissue. The expression levels of immune‑related genes were analyzed, and the differentially expressed genes (DEGs) between the three groups were compared. Protein‑protein interaction networks were established using Cytoscape. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were carried out to determine the main functions associated with the DEGs and keloid‑associated pathways. The results identified hub genes in the N and I groups, including C‑C motif chemokine receptor (CCR) 1, CCR7, CD40 ligand, C‑X‑C motif chemokine ligand 9, IL‑6 and IL‑10. The hub genes in the I and the K groups included IL‑10, IL‑6, IL‑13 and CD86. The expression levels of these genes were verified using reverse transcription‑quantitative PCR. The results demonstrated that IL‑6 expression levels were significantly increased in the I group compared with the N group (P=0.0111). CCR7 levels significantly differed between all three groups (P<0.017). The results of GO analysis suggested that the hub genes in the I and N groups may be associated with ‘regulation of lymphocyte activation’ and ‘T‑cell activation’. Similar results were also observed between the I and K groups, which may play an important role in keloid initiation and formation. In conclusion, CCR7, IL‑10 and IL‑6 may be important in keloid initiation and formation. These findings provided insight into the pathogenesis of keloids and may help identify novel immune‑related therapeutic targets for this condition.

View Figures

View References

1	Brown JJ, Ollier W, Arscott G, Ke X, Lamb J, Day P and Bayat A: Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-caribbeans. Exp Dermatol. 17:610–613. 2008. View Article : Google Scholar : PubMed/NCBI
2	Chung S, Nakashima M, Zembutsu H and Nakamura Y: Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci. 87:563–573. 2011. View Article : Google Scholar : PubMed/NCBI
3	Glass DA II: Current understanding of the genetic causes of keloid formation. J Investig Dermatol Symp Proc. 18:S50–S53. 2017. View Article : Google Scholar : PubMed/NCBI
4	Tsai CH and Ogawa R: Keloid research: Current status and future directions. Scars Burn Heal. 5:20595131198686592019.PubMed/NCBI
5	Song KX, Liu S, Zhang MZ, Liang WZ, Liu H, Dong XH, Wang YB and Wang XJ: Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate. J Zhejiang Univ Sci B. 19:853–862. 2018. View Article : Google Scholar : PubMed/NCBI
6	Ogawa R: Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 18:6062017. View Article : Google Scholar : PubMed/NCBI
7	Diaz A, Tan K, He H, Xu H, Cueto I, Pavel AB, Krueger JG and Guttman-Yassky E: Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy. J Eur Acad Dermatol Venereol. 34:e161–e164. 2020. View Article : Google Scholar : PubMed/NCBI
8	Shi CK, Zhao YP, Ge P and Huang GB: Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway. Eur Rev Med Pharmacol Sci. 23:9085–9092. 2019.PubMed/NCBI
9	Gankande TU, Wood FM, Edgar DW, Duke JM, DeJong HM, Henderson AE and Wallace HJ: A modified vancouver scar scale linked with TBSA (mVSS-TBSA): Inter-rater reliability of an innovative burn scar assessment method. Burns. 39:1142–1149. 2013. View Article : Google Scholar : PubMed/NCBI
10	Wang CH, Shan MJ, Liu H, Hao Y, Song KX, Wu HW, Meng T, Feng C, Qi Z, Wang Z and Wang YB: Hyperbaric oxygen treatment on keloid tumor immune gene expression. Chin Med J (Engl). 134:2205–2213. 2021.PubMed/NCBI
11	Privé F, Luu K, Vilhjálmsson BJ and Blum M: Performing highly efficient genome scans for local adaptation with r package pcadapt version 4. Mol Biol Evol. 37:2153–2154. 2020. View Article : Google Scholar : PubMed/NCBI
12	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
13	Huang DW, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
14	Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH and Bork P: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI
15	Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
16	Ni M, Liu X, Wu J, Zhang D, Tian J, Wang T, Liu S, Meng Z, Wang K, Duan X, et al: Identification of candidate biomarkers correlated with the pathogenesis and prognosis of non-small cell lung cancer via integrated bioinformatics analysis. Front Genet. 9:4692018. View Article : Google Scholar : PubMed/NCBI
17	Yan J, Zuo G, Sherchan P, Huang L, Ocak U, Xu W Travis Z, Wang W, Zhang J and Tang J: CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice. Neurotherapeutics. 17:1170–1183. 2020. View Article : Google Scholar : PubMed/NCBI
18	Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and Lin CY: cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
19	Song X, Du R, Gui H, Zhou M, Zhong W, Mao C and Ma J: Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Oncol Rep. 43:133–146. 2020.PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Zhang Q, Yamaza T, Kelly AP, Shi S, Wang S, Brown J, Wang L, French SW, Shi S and Le AD: Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis. PLoS One. 4:e77982009. View Article : Google Scholar : PubMed/NCBI
22	Limandjaja GC, Niessen FB, Scheper RJ and Gibbs S: The keloid disorder: Heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 8:3602020. View Article : Google Scholar : PubMed/NCBI
23	van den Broek LJ, Limandjaja GC, Niessen FB and Gibbs S: Human hypertrophic and keloid scar models: Principles, limitations and future challenges from a tissue engineering perspective. Exp Dermatol. 23:382–386. 2014. View Article : Google Scholar : PubMed/NCBI
24	Tan S, Khumalo N and Bayat A: Understanding keloid pathobiology from a quasi-neoplastic perspective: Less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Front Immunol. 10:18102019. View Article : Google Scholar : PubMed/NCBI
25	Karnell JL, Rieder SA, Ettinger R and Kolbeck R: Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond. Adv Drug Deliv Rev. 141:92–103. 2019. View Article : Google Scholar : PubMed/NCBI
26	Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H and Lenz HJ: CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation-A target for novel cancer therapy. Cancer Treat Rev. 63:40–47. 2018. View Article : Google Scholar : PubMed/NCBI
27	Zhong L, Bian L, Lyu J, Jin H, Liu Z, Lyu L and Lu D: Identification and integrated analysis of microRNA expression profiles in keloid. J Cosmet Dermatol. 17:917–924. 2018. View Article : Google Scholar : PubMed/NCBI
28	Ghazizadeh M: Essential role of IL-6 signaling pathway in keloid pathogenesis. J Nippon Med Sch. 74:11–22. 2007. View Article : Google Scholar : PubMed/NCBI
29	Jin Q, Gui L, Niu F, Yu B, Lauda N, Liu J, Mao X and Chen Y: Macrophages in keloid are potent at promoting the differentiation and function of regulatory T cells. Exp Cell Res. 362:472–476. 2018. View Article : Google Scholar : PubMed/NCBI
30	Suzuki M, Yokota M, Matsumoto T and Ozaki S: Synergic effects of CD40 and CD86 silencing in dendritic cells on the control of allergic diseases. Int Arch Allergy Immunol. 177:87–96. 2018. View Article : Google Scholar : PubMed/NCBI
31	Mburu YK, Wang J, Wood MA, Walker WH and Ferris RL: CCR7 mediates inflammation-associated tumor progression. Immunol Res. 36:61–72. 2006. View Article : Google Scholar : PubMed/NCBI
32	Huang H, Fu S and Liu D: Detection and analysis of the hedgehog signaling pathway-related long non-coding RNA (lncRNA) expression profiles in keloid. Med Sci Monit. 24:9032–9044. 2018. View Article : Google Scholar : PubMed/NCBI
33	Spangler JB, Moraga I, Mendoza JL and Garcia KC: Insights into cytokine-receptor interactions from cytokine engineering. Annu Rev Immunol. 33:139–167. 2015. View Article : Google Scholar : PubMed/NCBI